EUVIMEDEUVIMED entdecken
Crossref

FGF‐21 and 8‐OHdG Biomarkers in Drug‐Naïve Children With Autism Spectrum Disorder

Samuel Baraúna iD, Gérssica Sylvestre, Laiana Quagliato iD

International Journal of Developmental Neuroscience · 2025-11 · 85 (7)

DOI: 10.1002/jdn.70069 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Developmental Neuroscience, online erschienen am 19.11.2025. Verfasst von Samuel Baraúna und 2 weiteren Autor:innen. Beteiligte Einrichtung: Child and Adolescent Psychiatry Lab. Psychiatry Institute, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil. Hauptthemen laut MEDLINE: Autism Spectrum Disorder, Fibroblast Growth Factors, Deoxyguanosine. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 18 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Autism spectrum disorder (ASD) is a neuropsychiatric condition characterized by significant difficulties in social communication and repetitive behaviours, with multifactorial causes that include genetic predisposition and environmental factors. Recent studies have highlighted altered levels of specific biomarkers associated with DNA damage in children with ASD. These alterations become more evident due to increased oxidative stress, a common feature in individuals diagnosed with ASD. This study aimed to investigate plasma levels of FGF‐21—an endogenous protein with metabolic and, primarily, neuroprotective functions—and its relationship with the biomarker 8OHdG, which is widely recognized as an indicator of oxidative stress and cellular and DNA damage. The research included 29 drug‐naive children diagnosed with ASD and 31 healthy control children. The 8OHdG result showed a statistically significant difference when comparing patients diagnosed with ASD to healthy controls ( t = 2.768, df = 58, p = 0.004), indicating a relevant difference in the levels of this biomarker and DNA damage between patients with ASD and controls. In contrast, the analysis of FGF‐21 ( p = 0.44) did not show a significant difference in both groups. These findings pave the way for future research that may lead to innovative therapeutic approaches for the treatment of children with ASD, focusing on reducing oxidative stress and DNA repair.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Autism Spectrum DisorderFibroblast Growth FactorsDeoxyguanosineHumansMaleFemaleChildBiomarkers8-Hydroxy-2'-DeoxyguanosineChild, PreschoolOxidative StressDNA Damage

Stichwörter der Autor:innen

8‐OHdGFGF‐21autism spectrum disorder (ASD)inflammationoxidative stress

Substanzen

Fibroblast Growth FactorsBiomarkers8-Hydroxy-2'-DeoxyguanosineDeoxyguanosinefibroblast growth factor 21

Autor:innen und Institutionen

  • Child and Adolescent Psychiatry Lab. Psychiatry Institute, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.

ORCID-Profile: Samuel Baraúna, Laiana Quagliato

Zitieren

APA

Baraúna, S., Sylvestre, G., & Quagliato, L. (2025). FGF‐21 and 8‐OHdG Biomarkers in Drug‐Naïve Children With Autism Spectrum Disorder. International Journal of Developmental Neuroscience, 85(7). https://doi.org/10.1002/jdn.70069

Vancouver

Baraúna S, Sylvestre G, Quagliato L. FGF‐21 and 8‐OHdG Biomarkers in Drug‐Naïve Children With Autism Spectrum Disorder. International Journal of Developmental Neuroscience. 2025;85(7). doi:10.1002/jdn.70069

BibTeX
@article{Barana2025,
  author = {Baraúna, Samuel and Sylvestre, Gérssica and Quagliato, Laiana},
  title = {FGF‐21 and 8‐OHdG Biomarkers in Drug‐Naïve Children With Autism Spectrum Disorder},
  journal = {International Journal of Developmental Neuroscience},
  year = {2025},
  volume = {85},
  number = {7},
  doi = {10.1002/jdn.70069}
}
Kostenlos starten →